ESC 365 - Incidence, presentation, treatment and outcome of patients with myocardial infarction type 2 in routine clinical practice

ESC Premium Access

Incidence, presentation, treatment and outcome of patients with myocardial infarction type 2 in routine clinical practice

Session: Challenges with anticoagulants and antithrombotics in acute coronary syndrome

Topic: Infarction acute phase STEMI

Speaker: Doctor D. Radovanovic (Zurich, CH)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Dragana Radovanovic

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich (Switzerland)

0 follower

4 more presentations in this session

State of the art in treatment of acute coronary syndrome patients in need of oral anticoagulation.

Speaker: Doctor W. Dewilde (Bonheiden, BE)

Comparative impact of preexisting and new-onset atrial fibrillation on long-term mortality in STEMI patients admitted for primary PCI

Speaker: Doctor I. Veljic (Belgrade, RS)

New onset atrial fibrillation in st-segment elevation myocardial infarction: predictors and impact on therapy and mortality

Speaker: Doctor K. Hyde Congo (Evora, PT)

Future direction for research in treatment of acute coronary syndrome patients in need of oral anticoagulation.

Speaker: Doctor M. Lettino (Monza, IT)

Access the full session

Challenges with anticoagulants and antithrombotics in acute coronary syndrome

Speakers: Doctor D. Radovanovic, Doctor W. Dewilde, Doctor I. Veljic, Doctor K. Hyde Congo, Doctor M. Lettino

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources